190 related articles for article (PubMed ID: 8835051)
1. Technical and interpretive problems of peripheral nerve stimulation in monitoring neuromuscular blockade in the intensive care unit.
Rudis MI; Guslits BG; Zarowitz BJ
Ann Pharmacother; 1996 Feb; 30(2):165-72. PubMed ID: 8835051
[TBL] [Abstract][Full Text] [Related]
2. A prospective, randomized, controlled evaluation of peripheral nerve stimulation versus standard clinical dosing of neuromuscular blocking agents in critically ill patients.
Rudis MI; Sikora CA; Angus E; Peterson E; Popovich J; Hyzy R; Zarowitz BJ
Crit Care Med; 1997 Apr; 25(4):575-83. PubMed ID: 9142020
[TBL] [Abstract][Full Text] [Related]
3. Monitoring neuromuscular blockade in the intensive care unit: the peripheral nerve stimulator.
Rowlee SC
Heart Lung; 1999; 28(5):352-62; quiz 363-4. PubMed ID: 10486453
[TBL] [Abstract][Full Text] [Related]
4. Clinical Practice Guidelines for Sustained Neuromuscular Blockade in the Adult Critically Ill Patient.
Murray MJ; DeBlock H; Erstad B; Gray A; Jacobi J; Jordan C; McGee W; McManus C; Meade M; Nix S; Patterson A; Sands MK; Pino R; Tescher A; Arbour R; Rochwerg B; Murray CF; Mehta S
Crit Care Med; 2016 Nov; 44(11):2079-2103. PubMed ID: 27755068
[TBL] [Abstract][Full Text] [Related]
5. Use of peripheral nerve stimulators to monitor patients with neuromuscular blockade in the ICU.
Kleinpell R; Bedrosian C; McCormick L; Kremer M; Bujalski L; Bronsted R
Am J Crit Care; 1996 Nov; 5(6):449-54. PubMed ID: 8922161
[TBL] [Abstract][Full Text] [Related]
6. Retrospective pharmacoeconomic evaluation of dosing vecuronium by peripheral nerve stimulation versus standard clinical assessment in critically ill patients.
Zarowitz BJ; Rudis MI; Lai K; Petitta A; Lulek M
Pharmacotherapy; 1997; 17(2):327-32. PubMed ID: 9085324
[TBL] [Abstract][Full Text] [Related]
7. Accurate monitoring of neuromuscular blockade using a peripheral nerve stimulator--a review.
Beemer GH; Reeves JH; Bjorksten AR
Anaesth Intensive Care; 1990 Nov; 18(4):490-6. PubMed ID: 2268016
[TBL] [Abstract][Full Text] [Related]
8. Management of pharmacologically induced neuromuscular blockade using peripheral nerve stimulation.
Loyola R; Dreher HM
Dimens Crit Care Nurs; 2003; 22(4):157-64; quiz 165-6. PubMed ID: 12893991
[TBL] [Abstract][Full Text] [Related]
9. Agreement between muscle movement and peripheral nerve stimulation in critically ill pediatric patients receiving neuromuscular blocking agents.
Peña O; Prestjohn S; Guzzetta CE
Heart Lung; 2000; 29(5):309-18. PubMed ID: 10986525
[TBL] [Abstract][Full Text] [Related]
10. Train-of-four: to use or not to use.
Tschida SJ; Hoey LL; Mather D; Vance-Bryan K
Pharmacotherapy; 1995; 15(4):546-50. PubMed ID: 7479212
[TBL] [Abstract][Full Text] [Related]
11. Monitoring neuromuscular blockade in the adult ICU.
Ford EV
Am J Crit Care; 1995 Mar; 4(2):122-30; quiz 131-2. PubMed ID: 7749444
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of peripheral nerve stimulators and relationship to possible errors in assessing neuromuscular blockade.
Mylrea KC; Hameroff SR; Calkins JM; Blitt CD; Humphrey LL
Anesthesiology; 1984 May; 60(5):464-6. PubMed ID: 6324617
[TBL] [Abstract][Full Text] [Related]
13. Monitoring neuromuscular blockade with calf stimulators.
Beemer GH
Anaesth Intensive Care; 1987 Nov; 15(4):375-8. PubMed ID: 2827537
[TBL] [Abstract][Full Text] [Related]
14. Prolonged paralysis in intensive care unit patients after the use of neuromuscular blocking agents: a review of the literature.
Watling SM; Dasta JF
Crit Care Med; 1994 May; 22(5):884-93. PubMed ID: 7910130
[TBL] [Abstract][Full Text] [Related]
15. Current therapeutic uses, pharmacology, and clinical considerations of neuromuscular blocking agents for critically ill adults.
Warr J; Thiboutot Z; Rose L; Mehta S; Burry LD
Ann Pharmacother; 2011 Sep; 45(9):1116-26. PubMed ID: 21828347
[TBL] [Abstract][Full Text] [Related]
16. Monitoring and preventive care of the paralyzed patient in respiratory failure.
Dulin PG; Williams CJ
Crit Care Clin; 1994 Oct; 10(4):815-29. PubMed ID: 8000928
[TBL] [Abstract][Full Text] [Related]
17. A review of neuromuscular blockade in the critically ill patient.
Burry L; HoSang M; Hynes-Gay P
Dynamics; 2001; 12(3):28-33; quiz 34-5. PubMed ID: 11982205
[TBL] [Abstract][Full Text] [Related]
18. [Value of monitoring muscle relaxation].
Jöhr M; Gerber H
Schweiz Med Wochenschr; 1996 Sep; 126(39):1649-53. PubMed ID: 8927968
[TBL] [Abstract][Full Text] [Related]
19. Monitoring of neuromuscular function.
Ali HH
Middle East J Anaesthesiol; 1989 Oct; 10(3):261-78. PubMed ID: 2637950
[TBL] [Abstract][Full Text] [Related]
20. A national survey of critical care nurses' practices related to administration of neuromuscular blocking agents.
Foster JG; Kish SK; Keenan CH
Am J Crit Care; 2001 May; 10(3):139-45. PubMed ID: 11340735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
